aea004

Andrew E. Aplin, PhD

Contact Dr. Aplin

233 South 10th Street
BLSB 522
Philadelphia, PA 19107

(215) 503-7296
(215) 923-9248 fax

Most Recent Peer-reviewed Publications

  1. ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
  2. CKS1 expression in melanocytic nevi and melanoma
  3. Response and resistance to paradox-breaking BRAF inhibitor in melanomas in vivo and Ex vivo
  4. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
  5. “If you want to go far, go together”
  6. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
  7. Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of klotho
  8. Dysregulated GPCR signaling and therapeutic options in uveal melanoma
  9. Co-Targeting HGF/cMET Signaling with MEK Inhibitors in metastatic uveal melanoma
  10. Running INTERFERONce on immunotherapy
  11. The Autophagy Receptor Adaptor p62 is Up-regulated by UVA Radiation in Melanocytes and in Melanoma Cells
  12. An in vivo reporter to quantitatively and temporally analyze the effects of CDK4/6 inhibitor-based therapies in melanoma
  13. Triple jeopardy for people with albinism
  14. The melanoma field with dendritic roots
  15. The state of melanoma: challenges and opportunities
  16. Targeting mutant NRAS signaling pathways in melanoma
  17. Of Mice and melanoma: PDX system for modeling personalized medicine
  18. Welcome to the New Year!
  19. MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma
  20. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization